Pertuzumab_x000D_

GAMPENRIEDER, SP; GREIL, R; HUBALEK, M; RINNERTHALER, G; STEGER, GG ArzneimittelPROFIL Pertuzumab, August 2013. 2013.

Pertuzumab beim metastasierten HER2-positiven Mammakarzinom

GAMPENRIEDER, SP; GREIL, R; HUBALEK, M; RINNERTHALER, G; STEGER, GG Journal of Medical Drug Reviews 2013. 2013. 3: 61-71.

Management of immunosuppression in the treatment of chronic lymphocytic leukemia

Auberger, J; Greil, R memo – Magazine of European Medical Oncology, 2013/1. 2013.

Systemische Therapie des prämenopausalen Mammakarzinoms

Ressler, S; Greil, R; Die Punkte. 2013.

Lenalidomide/Rituximab Maintenance After Induction With Fludarabine/Rituximab In Combination With Escalating Doses Of Lenalidomide In Previously Untreated Chronic Lymphocytic Leukemia (CLL): The Revlirit CLL5 AGMT Phase I/II Study, Final Results

Egle, A; Steurer, M; Gassner, FJ; Geisberger, R; Melchardt, T; Pleyer, L; Weiss, L; Fridrik, MA; Thaler, J; Lang, A; Greil, R; Blood (ASH Annual Meeting Abstracts). 2013. #4164:

Bid-ding for mercy: twisted killer in action.

Egle, A; Asslaber, D; Villunger, A; Pinon-Hofbauer, J; Cell Death Differ. 2013; 20(7):847-849

Topical evening primrose oil for reduction of bortezomib-induced skin reactions.

Auberger, J; Vogt, S; Hopfinger, G; Clausen, J; Greil, R; Ann Hematol. 2013; 92(7):995-996

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.

Hopfinger, G; Busch, R; Pflug, N; Weit, N; Westermann, A; Fink, AM; Cramer, P; Reinart, N; Winkler, D; Fingerle-Rowson, G; Stilgenbauer, S; Döhner, H; Kandler, G; Eichhorst, B; Hallek, M; Herling, M; Cancer. 2013; 119(12):2258-2267

What is causing my arthritis, doctor? A glimpse beyond the usual suspects in the pathogenesis of rheumatoid arthritis.

Pieringer, H; Studnicka-Benke, A; QJM. 2013; 106(3):219-228

Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.

Taylor, N; Melchardt, T; Grundbichler, M; Strasser, M; Egle, A; Greil, R; Ann Hematol. 2013; 92(7):1001-1002